On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
We have now added a new section called the "Assay History List" to the "At A Gla...